Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.

Charalambakis, Nikolaos; Kouloulias, Vassilis; Vaja, Helena; Pectasides, Dimitrios; Rampias, Theodoros; Economopoulos, Theofanis; Katsaounis, Panagiotis; Siolos, Spiros; Bartzi, Valentina; Perisanidis, Christos; Laschos, Konstantinos; Maragoudakis, Pavlos; Proikas, Konstantinos; Papadimitriou, Nikolaos; Papadogeorgakis, Nikolaos; Georgopoulou, Helen; Zygogianni, Anna; Artopoulou, Ioli; Pappa, Eleni; Dimitriadis, George; Psyrri, Amanda

Charalambakis, Nikolaos; Kouloulias, Vassilis; Vaja, Helena; Pectasides, Dimitrios; Rampias, Theodoros; Economopoulos, Theofanis; Katsaounis, Panagiotis; Siolos, Spiros; Bartzi, Valentina; Perisanidis, Christos; Laschos, Konstantinos; Maragoudakis, Pavlos; Proikas, Konstantinos; Papadimitriou, Nikolaos; Papadogeorgakis, Nikolaos; Georgopoulou, Helen; Zygogianni, Anna; Artopoulou, Ioli; Pappa, Eleni; Dimitriadis, George; Psyrri, Amanda.

Afiliação

Charalambakis N; Second Department of Internal Medicine Propaedeutic, Oncology Section, Attikon University Hospital, University of Athens Medical School Athens, Greece.

Front Oncol ; 3: 5, 2013.

Article em En | MEDLINE | ID: mdl-23373010